• Welcome, Guest. Please login or register.
    April 05, 2020, 09:42:00 PM

  • Login with username, password and session length

Sajid's dove

Tell everyone they can now find this site by typing this into their browser:

thalpal.com

Click to visit us on Facebook


If you have any problems registering or signing in, please send an email to: andythalpal@yahoo.com
Please do not send questions about thalassemia to this address.


Administrators
Andy
Danielle

Thalassemia Patients and Friends and thalpal © A. Battaglia 2019





55248 Posts in 5898 Topics by 6188 Members
Latest Member: jcemanuele

Forum Tip: 
You can now simply type thalpal.com into your browser and it will take you to this site. Tell your friends about this easy-to-remember name.
www.thalpal.com
« previous next »
Pages: 1 Go Down Print
Author Topic: Luspatercept vs. Sotatercept  (Read 4205 times)
CrazyPharm
Active Member
**
Offline Offline

Location: USA

Gender: Male
Posts: 43


« on: December 22, 2014, 04:51:44 AM »

Can anyone highlight the differences between Sotatercept and Luspatercept. Apparently Acceleron and Celgene will most likely be moving forward with only one of these drugs? does anyone have some info. on this?

Also, their phase II trial in Thalassemia received funding from Novartis. Confused but how does Novartis tie into this? I know Dr. Piga has worked with them but aside from that...bluntly speaking: what's in it for them?
Logged
Andy Battaglia
Administrator
Supreme Member
*****
Offline Offline

Location: In my heart, Maldives

Gender: Male
Posts: 8636


Will thal rule you or will you rule thal?


« Reply #1 on: December 22, 2014, 09:37:10 AM »

Contrary to popular perception, it is far more likely for a company like Novartis to buy a company for an already developing drug, than to develop one themselves. I would say Novartis has a potential future financial interest.
Logged

Andy

All we are saying is give thals a chance.
CrazyPharm
Active Member
**
Offline Offline

Location: USA

Gender: Male
Posts: 43


« Reply #2 on: December 22, 2014, 10:11:07 AM »

Thanks Andy, my thoughts exactly! Novartis seems to jump on Thalassemia drugs. On a different note: any idea when the Brand patent on Exjade expires?
Logged
ama
New Member
*
Offline Offline

Posts: 19


« Reply #3 on: December 22, 2014, 02:13:14 PM »

Exjade Patent is supposed to expire on April 5, 2019.
Logged
Pages: 1 Go Up Print 
« previous next »
Jump to:  

Powered by MySQL Powered by PHP Powered by SMF 1.1.21 | SMF © 2015, Simple Machines Valid XHTML 1.0! Valid CSS!